Image

Large Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast Cancer

Large Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast Cancer

Recruiting
18-70 years
Female
Phase N/A

Powered by AI

Overview

The study is a single-center, prospective, non-randomized controlled study. The primary objective is to examine the clinical outcomes of utilizing Deep Inspiration Breath Hold (DIBH) in conjunction with hypo-fractionated radiotherapy for patients diagnosed with left-sided breast cancer with a particular focus on its potential to reduce the incidence of cardiac-related clinical and subclinical events.Participants will revieve large segmentation sadiotherapy ± DIBH for left breast cancer and be followed up to gather their clinical cardiac imformation.

Eligibility

Inclusion Criteria:

  1. 18-70 years old, female, life expectancy > 5 years
  2. ECOG 0, 1, 2 points
  3. Pathologically diagnosed with left breast cancer and underwent breast-conserving surgery or modified radical mastectomy
  4. The patient will receive radiation therapy to the entire breast or chest wall ± the lymphatic drainage area above and below the clavicle ± the lymphatic drainage area in the axilla.
  5. No prior neoadjuvant chemotherapy or breast reconstruction.
  6. No active cardiac disease, myocardial infarction, or congestive cardiac failure at baseline.
  7. Patients can hold their breath for at least 30 seconds after training
  8. Patients who can be followed up and agree to follow the plan.
  9. Sign the consent form.

Exclusion Criteria:

  1. Lesions were observed on both sides of the breast.
  2. Diagnosis could not be confirmed by pathology.
  3. Distant metastasis was identified.
  4. The patient had undergone neoadjuvant chemotherapy or breast reconstruction surgery.
  5. Severe cardiac insufficiency; myocardial infarction or uncorrected unstable cardiac arrhythmia or uncorrected unstable angina within the last 3 months; or pericardial disorders
  6. The patient's New York Heart Association (NYHA) cardiac classification is within categories 2-4.
  7. A history of chronic lung disease, including conditions that may contribute to ductal dilatation, such as chronic obstructive pulmonary disease (COPD) and interstitial pneumonia.
  8. Previous mediastinal radiotherapy.
  9. Previous or concurrent second primary malignant tumor (except skin cancer that is not a malignant black pigmented tumor, papillary/follicular carcinoma of the thyroid, carcinoma in situ of the cervix, and contralateral non-invasive breast cancer).
  10. Irradiation of the lymphatic drainage area of the internal breast is required.

Study details
    Breast Cancer

NCT06660628

Peking Union Medical College Hospital

6 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.